Literature DB >> 14585368

Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.

Jeane Eliete Laguila Visentainer1, Sofia Rocha Lieber, Lígia Beatriz Lopes Persoli, Afonso Celso Vigorito, Francisco José Penteado Aranha, Kátia Aparecida de Brito Eid, Gislaine Borba Oliveira, Eliana Cristina Martins Miranda, Cármino Antonio de Souza.   

Abstract

OBJECTIVE: The aim of this study was to investigate whether the serum levels of soluble interleukin-2R (sIL-2R), tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma), IL-6, IL-10, and transforming growth factor-beta(1) (TGF-beta(1)) were associated with the development of acute graft-vs-host disease (aGVHD). PATIENTS AND METHODS: Serum cytokine levels were sequentially measured by sandwich enzyme-linked immunosorbent assay in 13 patients who had received full-match allogeneic hematopoietic stem cell transplantation (HSCT).
RESULTS: Serum sIL-2R and IL-10 levels from the 1st to the 15th week post transplantation were significantly higher in the group that developed aGVHD than in the group without aGVHD. sIL-2R levels increased in direct correlation to engraftment and at onset of aGVHD, whereas IL-10 levels increased transiently following HSCT. The mean TNF-alpha concentration in the first weeks after transplantation was augmented in the group that developed aGVHD. Furthermore, a decrease in TGF-beta(1) levels after engraftment was significantly associated with aGVHD. No correlation was found between aGVHD and the other cytokines.
CONCLUSIONS: These results support the idea that a balance between cytokines derived from type 1 and type 2 T-helper cells may be important in the development and control of aGVHD. Although sIL-2R, TNF-alpha, IL-10, and TGF-beta(1) levels have been correlated with aGVHD, sIL-2R levels at engraftment may provide a better parameter for early detection of aGVHD after allogeneic HSCT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14585368     DOI: 10.1016/j.exphem.2003.08.005

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  27 in total

Review 1.  Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality.

Authors:  John A Hansen
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

2.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

Authors:  Sophie Paczesny; Frances T Hakim; Joseph Pidala; Kenneth R Cooke; Julia Lathrop; Linda M Griffith; John Hansen; Madan Jagasia; David Miklos; Steven Pavletic; Robertson Parkman; Estelle Russek-Cohen; Mary E D Flowers; Stephanie Lee; Paul Martin; Georgia Vogelsang; Marc Walton; Kirk R Schultz
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-30       Impact factor: 5.742

Review 3.  Pleiotropic effects of transforming growth factor-β in hematopoietic stem-cell transplantation.

Authors:  Stephanie M Coomes; Bethany B Moore
Journal:  Transplantation       Date:  2010-12-15       Impact factor: 4.939

Review 4.  Discovery and validation of graft-versus-host disease biomarkers.

Authors:  Sophie Paczesny
Journal:  Blood       Date:  2012-11-19       Impact factor: 22.113

5.  Cytokine gene polymorphisms and graft-versus-host disease in children after matched sibling hematopoietic stem cell transplantation: a single-center experience.

Authors:  Evgenios Goussetis; Ioanna Varela; Ioulia Peristeri; Vasiliki Kitra; Kleopatra Spanou; Olga Moraloglou; Anna Paisiou; Sofia Karatasaki; Alexandra Soldatou; Nikki Constantinidou; Stelios Graphakos
Journal:  Cell Mol Immunol       Date:  2011-02-28       Impact factor: 11.530

Review 6.  Graft-versus-host disease biomarkers: omics and personalized medicine.

Authors:  Sophie Paczesny; Nisha Raiker; Sam Brooks; Christy Mumaw
Journal:  Int J Hematol       Date:  2013-09       Impact factor: 2.490

Review 7.  Plasma biomarkers in graft-versus-host disease: a new era?

Authors:  Sophie Paczesny; John E Levine; Thomas M Braun; James L M Ferrara
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

8.  A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation.

Authors:  K Riesner; M Kalupa; Y Shi; S Elezkurtaj; O Penack
Journal:  Bone Marrow Transplant       Date:  2015-11-23       Impact factor: 5.483

9.  TNF, LTA and TGFB1 genotype distributions among acute graft-vs-host disease subsets after HLA-matched unrelated hematopoietic stem cell transplantation: a pilot study.

Authors:  R Shah; S T Selby; B Yokley; R S Slack; C K Hurley; P E Posch
Journal:  Tissue Antigens       Date:  2009-04-08

10.  Differentiation of gram-negative bacterial aerosol exposure using detected markers in bronchial-alveolar lavage fluid.

Authors:  David Wunschel; Bobbie-Jo Webb-Robertson; Charles W Frevert; Shawn Skerrett; Nat Beagley; Alan Willse; Heather Colburn; Kathryn Antolick
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.